Four details:
1. The center is exploring the safety and efficacy of the prodisc Vivo and SK for the treatment of two-level cervical disc disease.
2. The Mobi-C disc will be used as the control in the study. For every two patients who receive a prodisc C or SK, a third will receive a Mobic-C disc.
3. The Synergy Disc trial could be a better suited option for patients requiring a single-level disc replacement, according to a May 21 news release. Patients who already have had a cervical disc replacement at one level can participate in the Synergy trial.
4. The Synergy Disc, designed by neurosurgeon Neil Duggal, MD, is intended for the reconstruction of a disc between C3-C7 after a single discectomy.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
